Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Hydroxytyrosol

Q: Is supplement hydroxytyrosol better than olive oil?

Concentrated supplements ensure a known dose. Good extra-virgin olive oil delivers hydroxytyrosol with the rest of its beneficial fatty acid matrix.

PhytochemicalPolyphenolBest with a meal

Phenolic compound found in olives, olive oil, and especially olive mill wastewater. The most-studied olive polyphenol. EFSA has approved a health claim that 5 mg/day of hydroxytyrosol and its derivatives from olive oil protects LDL from oxidative damage. Strongest clinical evidence is in the FOOD MATRIX — extra-virgin olive oil and the Mediterranean diet (PREDIMED) — rather than for isolated hydroxytyrosol supplements (Lopez-Huertas 2017 was null at 5 and 25 mg/day).

Quick decision guide

May help most

Adults who want to operationalise the EFSA olive-polyphenol claim. The cleanest path is high-polyphenol extra-virgin olive oil (~20 g/day) within a Mediterranean dietary pattern; isolated hydroxytyrosol supplements have weaker independent evidence.

Common dosing range

EFSA-claim threshold: 5 mg/day hydroxytyrosol + derivatives. Supplements typically deliver 5–50 mg/day. PREDIMED's effective intake came from ~50 g/day EVOO.

When to expect effects

Weeks for LDL oxidation biomarkers; years for hard CV outcomes as in PREDIMED.

Watch out for

Isolated hydroxytyrosol supplements have not consistently reproduced the food-matrix benefits. The clearest evidence is for the whole olive-oil + Mediterranean-diet pattern, not the pill.

Evidence snapshot

LDL oxidation protection (EFSA claim)Moderate

HDL function improvementModerate

Hard CV event reduction (food matrix)Moderate (PREDIMED)

Isolated hydroxytyrosol supplementLow

What is it

Hydroxytyrosol is a phenolic compound found in olives, olive oil, and especially olive mill wastewater; it is sold as a polyphenolic antioxidant supplement.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You want to operationalise the EFSA olive-polyphenol health claim — most efficiently by using high-polyphenol extra-virgin olive oil daily within a Mediterranean dietary pattern

You have prehypertension or mild dyslipidemia and want a low-risk dietary lever

You don't tolerate olive oil and want the polyphenol content in capsule form — accepting that isolated supplements have less robust evidence

You're already on a Mediterranean dietary pattern and want to be sure your olive oil is genuinely high-polyphenol (look for early-harvest, peppery taste)

Probably skip if…

You're hoping an isolated hydroxytyrosol supplement will do what EVOO + Mediterranean diet does — the food-matrix evidence doesn't transfer cleanly to the pill (Lopez-Huertas 2017 null)

You're substituting hydroxytyrosol supplements for actual dietary change

You already eat 2–3 tbsp EVOO/day on a Mediterranean dietary pattern — adding supplemental hydroxytyrosol adds little

You have known olive allergy (rare but possible)

You're using ultra-high-dose supplements (100+ mg/day) marketed for cancer prevention or longevity — evidence doesn't support these claims

Evidence at a glance

Goal	Effect	Best fit	Time
Protection of LDL from oxidative damage (EFSA-approved claim) Good Evidence	Dose-dependent reduction in oxidised LDL and F2-isoprostanes; HDL +0.025 mmol/L per ~150 mg/kg added phenolic content per EUROLIVE	Adults consuming high-polyphenol extra-virgin olive oil at ~20 g/day; less certain for isolated hydroxytyrosol supplements	Weeks for oxidative-damage biomarkers
Cardiovascular event reduction (Mediterranean diet with EVOO) Good Evidence	~30% reduction in major CV events over 5 years in PREDIMED EVOO arm vs low-fat control	Adults with elevated CV risk who can adopt a Mediterranean dietary pattern with high-polyphenol EVOO	5 years (PREDIMED follow-up)
HDL function (efflux capacity, atherogenic composition) Limited Evidence	Improved HDL efflux capacity and reduced atherogenic HDL lipid composition with phenol-rich olive oil	Adults with HDL-dysfunction phenotype using high-polyphenol EVOO	Weeks of consistent high-polyphenol intake
Blood pressure Mixed Evidence	Null in Lopez-Huertas 2017; small inconsistent signals in other trials	None clearly established	Not consistently established

Protection of LDL from oxidative damage (EFSA-approved claim)

Good Evidence

Effect: Dose-dependent reduction in oxidised LDL and F2-isoprostanes; HDL +0.025 mmol/L per ~150 mg/kg added phenolic content per EUROLIVE
Best fit: Adults consuming high-polyphenol extra-virgin olive oil at ~20 g/day; less certain for isolated hydroxytyrosol supplements
Time: Weeks for oxidative-damage biomarkers

Cardiovascular event reduction (Mediterranean diet with EVOO)

Good Evidence

Effect: ~30% reduction in major CV events over 5 years in PREDIMED EVOO arm vs low-fat control
Best fit: Adults with elevated CV risk who can adopt a Mediterranean dietary pattern with high-polyphenol EVOO
Time: 5 years (PREDIMED follow-up)

HDL function (efflux capacity, atherogenic composition)

Limited Evidence

Effect: Improved HDL efflux capacity and reduced atherogenic HDL lipid composition with phenol-rich olive oil
Best fit: Adults with HDL-dysfunction phenotype using high-polyphenol EVOO
Time: Weeks of consistent high-polyphenol intake

Blood pressure

Mixed Evidence

Effect: Null in Lopez-Huertas 2017; small inconsistent signals in other trials
Best fit: None clearly established
Time: Not consistently established

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Protection of LDL from oxidative damage (EFSA-approved claim)

Supplement benefit

Good Evidence

EFSA approved a health claim in 2011 specifying that 5 mg/day of hydroxytyrosol and its derivatives from olive oil reduces LDL oxidative damage. The EUROLIVE crossover RCT (n=200) showed a clean biological gradient: olive oils with low, medium, and high phenolic content produced dose-dependent reductions in oxidised LDL and F2-isoprostanes, with parallel HDL increases. The evidence is for the FOOD MATRIX (olive oil), not specifically for isolated hydroxytyrosol supplements — the Lopez-Huertas 2017 supplement-only RCT at 5 and 25 mg/day was null for lipid endpoints.

Effect size

Dose-dependent reduction in oxidised LDL and F2-isoprostanes; HDL +0.025 mmol/L per ~150 mg/kg added phenolic content per EUROLIVE

Time to effect

Weeks for oxidative-damage biomarkers

Best fit

Adults consuming high-polyphenol extra-virgin olive oil at ~20 g/day; less certain for isolated hydroxytyrosol supplements

Less likely

Adults expecting isolated supplements to reproduce the food-matrix benefit

Bottom line: The food-matrix evidence is solid. The isolated-supplement evidence is weaker — operationalise this via high-polyphenol EVOO, not capsules.

Evidence is mixed

EFSA approved the LDL-oxidation claim based on food-matrix (olive oil) evidence. Isolated hydroxytyrosol supplements have not reliably reproduced the lipid effects — Lopez-Huertas 2017 was null at the EFSA-claim dose of 5 mg/day and at 25 mg/day.

SourceEFSA Panel on Dietetic Products, 2011 — EFSA Journal Lopez-Huertas et al., 2017 — European Journal of Nutrition· conflicting

SourceEFSA Panel on Dietetic Products, 2011 — EFSA Journal Covas et al. (EUROLIVE), 2006 — Annals of Internal Medicine

Cardiovascular event reduction (Mediterranean diet with EVOO)

Disease adjunct

Good Evidence

The PREDIMED trial (Estruch 2018 NEJM) is the strongest clinical-outcome evidence for olive polyphenols in context: 7,447 high-CV-risk adults randomised to Mediterranean diet + 50 g/day EVOO, Med diet + 30 g/day mixed nuts, or low-fat control. The EVOO + Med-diet arm showed ~30% reduction in major cardiovascular events over ~5 years. Hydroxytyrosol and other olive polyphenols are part of why EVOO seems to drive the benefit, but the trial is for the dietary pattern, not for isolated polyphenols. Don't expect a hydroxytyrosol pill to replicate this on top of a Western diet.

Effect size

~30% reduction in major CV events over 5 years in PREDIMED EVOO arm vs low-fat control

Time to effect

5 years (PREDIMED follow-up)

Best fit

Adults with elevated CV risk who can adopt a Mediterranean dietary pattern with high-polyphenol EVOO

Less likely

Adults using isolated hydroxytyrosol supplements without changing their overall diet

Bottom line: The Mediterranean diet + EVOO combination has real CV event reduction. The reductionist 'hydroxytyrosol pill' substitute does not.

SourceEstruch et al. (PREDIMED), 2018 — New England Journal of Medicine

HDL function (efflux capacity, atherogenic composition)

Mechanism only

Limited Evidence

Hernáez 2014 showed phenol-rich olive oil improved HDL cholesterol efflux capacity and reduced HDL's atherogenic lipid composition vs low-phenol olive oil. This is mechanistically important because HDL FUNCTION (not just HDL quantity) is what mediates cardiovascular protection. The signal supports olive polyphenols' biological plausibility as cardiovascular-protective agents but does not by itself justify isolated supplement use.

Effect size

Improved HDL efflux capacity and reduced atherogenic HDL lipid composition with phenol-rich olive oil

Time to effect

Weeks of consistent high-polyphenol intake

Best fit

Adults with HDL-dysfunction phenotype using high-polyphenol EVOO

Less likely

Adults expecting biomarker change from isolated hydroxytyrosol supplements

Bottom line: Real mechanistic support for olive polyphenols. Still mostly a food-matrix story.

SourceHernáez et al., 2014 — Atherosclerosis

Blood pressure

Supplement benefit

Mixed Evidence

Some small studies suggest hydroxytyrosol-rich olive products produce modest BP reductions, but the dedicated isolated-supplement trial (Lopez-Huertas 2017) showed no significant BP effect at 5 or 25 mg/day for 12 weeks. The cocoa-flavanol BP literature is much stronger than the hydroxytyrosol BP literature. Don't take hydroxytyrosol expecting meaningful BP control.

Effect size

Null in Lopez-Huertas 2017; small inconsistent signals in other trials

Time to effect

Not consistently established

Best fit

None clearly established

Less likely

Adults expecting meaningful BP reduction from a hydroxytyrosol supplement

Bottom line: Not a BP supplement. If you want a polyphenol BP lever, cocoa flavanols have stronger evidence.

SourceLopez-Huertas et al., 2017 — European Journal of Nutrition

How it works

Hydroxytyrosol has potent in vitro radical scavenging activity due to its catechol structure. It is well absorbed orally, undergoes phase II conjugation, and circulates as glucuronide and sulfate metabolites that retain some bioactivity. The EFSA recognizes a health claim for olive oil polyphenols (including hydroxytyrosol and oleuropein) protecting blood lipids from oxidative stress when at least 5 mg/day is consumed.

How to take it

1. Typical dose

• EFSA health-claim threshold: 5 mg/day hydroxytyrosol + derivatives (achievable with ~20 g/day high-polyphenol EVOO) • Supplements typically deliver 5–50 mg/day • Most studied food intake: ~50 g/day EVOO (PREDIMED) • Take with meals containing some fat for steady absorption (relevant for capsule and food alike)

2. Higher studied dose

Lopez-Huertas 2017 used 25 mg/day for 12 weeks without adverse effects but also without lipid benefit. Higher doses have been tested short-term in mechanistic studies. No formal safety ceiling but no advantage demonstrated above 25–50 mg/day either.

3. Timing

With meals for steady absorption. The food-matrix evidence (PREDIMED, EUROLIVE) used olive oil consumed at meals across the day.

4. With food

With food (containing some fat).

5. Split dosing

Single daily dose for supplements is fine. For dietary EVOO, spread across meals (cooking and finishing).

6. How long to try

Indefinite as part of a dietary pattern. The polyphenol benefits don't 'stack' over time the way medications do — consistency of intake matters more than duration.

What to track

Olive-oil quality (early harvest, peppery taste, robust polyphenol content) — many supermarket EVOOs are too refined to meet the 5 mg/day threshold easily

LDL and HDL on routine cholesterol panels at 3–6 months

BP if you're tracking lifestyle CV lever — don't expect dramatic changes from hydroxytyrosol specifically

Overall Mediterranean-diet adherence — EVOO without the diet pattern is half the story

Olive allergy symptoms (very rare): hives, itching after exposure

Bottom line: The cleanest path to the hydroxytyrosol benefit is high-polyphenol EVOO within a Mediterranean diet, not an isolated capsule.

4 commercial forms

Compare the main delivery options and what they’re best suited for.

Extra-virgin olive oil (high-polyphenol, early harvest)

Best-evidenced

The form of hydroxytyrosol delivery with the strongest clinical-outcome evidence (PREDIMED, EUROLIVE). High-quality early-harvest EVOO contains 300+ mg/kg total phenolics; ~20 g (1.5 tbsp) meets the EFSA 5 mg/day threshold. Peppery, slightly bitter taste signals high polyphenol content.

Whole-food matrix; the form with hard CV outcome data.

Standard supermarket EVOO

Variable

Many commercial EVOOs are blended or late-harvest and have lower polyphenol content (sometimes <100 mg/kg). Meeting the EFSA threshold requires more oil per day. Quality varies dramatically between brands and harvest years.

Variable polyphenol content; may not deliver claim-relevant doses at typical use.

Hydroxytyrosol supplement capsule

Less-evidenced

Isolated hydroxytyrosol extracted from olive mill wastewater or olive leaf, typically 5–50 mg/capsule. Direct lipid-and-BP-outcome RCT (Lopez-Huertas 2017) was null at 5 and 25 mg/day — the food-matrix benefits don't reliably reproduce in capsule form.

Absorption is fine; the issue is whether the isolated molecule reproduces food-matrix effects.

Olive-leaf extract (oleuropein-rich)

Different evidence

Olive-leaf extracts are standardised to oleuropein rather than hydroxytyrosol. Some BP-lowering signals in small trials but a distinct evidence base from hydroxytyrosol. Not interchangeable.

Oleuropein-rich; not the same active as direct hydroxytyrosol.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

very well tolerated at typical intakeoccasional mild GI upset at high supplement doses

Serious risks

No serious safety signals at typical food or supplement doses. Hydroxytyrosol has a long history of human dietary consumption through olives and olive oil.
SourceMSKCC About Herbs — Olive — Memorial Sloan Kettering Cancer Center

Who should avoid it

People with known olive allergy (rare).
Anyone hoping a hydroxytyrosol supplement will substitute for dietary change — the food-matrix evidence doesn't transfer to the capsule.
SourceLopez-Huertas et al., 2017 — European Journal of Nutrition

Pregnancy & breastfeeding

Hydroxytyrosol from olive oil and culinary olive intake is safe in pregnancy at dietary levels (olive oil is a Mediterranean-diet staple consumed throughout pregnancy). Isolated high-dose hydroxytyrosol supplements have not been studied in pregnancy and are not necessary — discuss with your obstetrician if you want to use them beyond the EFSA food-claim intake.

SourceMSKCC About Herbs — Olive — Memorial Sloan Kettering Cancer Center

Bottom line: Among the safest polyphenols. The real risk is buying an under-evidenced supplement instead of using high-quality EVOO.

Interactions

antihypertensive medicationsMinor

Olive polyphenols may modestly support BP-lowering effects. Practical impact at typical intake is small; monitor BP when adopting a Mediterranean diet pattern.

SourceMSKCC About Herbs — Olive — Memorial Sloan Kettering Cancer Center

anticoagulants (warfarin)Minor

Olive polyphenols have mild antiplatelet activity in vitro. Clinically significant warfarin interaction is rare at typical intakes; monitor INR if substantially increasing olive-oil intake or starting high-dose supplements.

diabetes medicationsMinor

Mediterranean dietary pattern with EVOO modestly improves insulin sensitivity. Practical impact on diabetes medication dosing is usually small; monitor glucose when changing dietary pattern substantially.

Food sources

Food	Amount	%DV
Extra-virgin olive oil, high-polyphenol	1.5 tbsp / 20 g (5+ mg hydroxytyrosol + derivatives — meets EFSA threshold)	—
Extra-virgin olive oil, standard supermarket	1.5 tbsp / 20 g (2–10 mg, brand-dependent)	—
Refined / 'light' olive oil	1.5 tbsp / 20 g (<1 mg — most polyphenols removed by refining)	—
Olives, black, ripe	10 olives (~1–3 mg)	—
Olives, green	10 olives (~2–5 mg)	—
Olive leaf extract (supplement)	Typical capsule (oleuropein-standardised; different active than hydroxytyrosol)	—

Extra-virgin olive oil, high-polyphenol

Amount: 1.5 tbsp / 20 g (5+ mg hydroxytyrosol + derivatives — meets EFSA threshold)
%DV: —

Extra-virgin olive oil, standard supermarket

Amount: 1.5 tbsp / 20 g (2–10 mg, brand-dependent)
%DV: —

Refined / 'light' olive oil

Amount: 1.5 tbsp / 20 g (<1 mg — most polyphenols removed by refining)
%DV: —

Olives, black, ripe

Amount: 10 olives (~1–3 mg)
%DV: —

Olives, green

Amount: 10 olives (~2–5 mg)
%DV: —

Olive leaf extract (supplement)

Amount: Typical capsule (oleuropein-standardised; different active than hydroxytyrosol)
%DV: —

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

Hydroxytyrosol content stated in mg per serving (target the EFSA 5 mg/day threshold if using a supplement)

For dietary intake: high-polyphenol extra-virgin olive oil — early harvest, peppery taste, low free-acidity, brand publishes polyphenol content (or has an organic / DOP / PDO designation)

Third-party tested (especially relevant for capsules — concentrated phenolic supplements can be variable)

Single-ingredient hydroxytyrosol or olive-extract capsule if supplementing — avoid 'antioxidant blends' that hide hydroxytyrosol content

Cost-per-mg comparison — EVOO is usually the most cost-effective hydroxytyrosol delivery vehicle by a wide margin

Be skeptical of…

Cancer prevention or treatment claims — preclinical / mechanistic only, no human RCT evidence

'Anti-aging' or longevity claims at high doses — not supported by clinical trials

'Most powerful antioxidant' marketing — generic claim that does not by itself indicate clinical benefit

Claims that isolated hydroxytyrosol supplements reproduce the Mediterranean-diet benefits — they don't, per Lopez-Huertas 2017

Mega-dose products (100+ mg/day) marketed for daily long-term use — no demonstrated benefit beyond the EFSA threshold dose

Olive-leaf-extract / 'oleuropein' products marketed as antibiotic / antiviral cures — these are separate claims from hydroxytyrosol's evidence base

Frequently asked questions

Is supplement hydroxytyrosol better than olive oil?⌄

Concentrated supplements ensure a known dose. Good extra-virgin olive oil delivers hydroxytyrosol with the rest of its beneficial fatty acid matrix.

References by claim

Protection of LDL from oxidative damage (EFSA-approved claim)

EFSA Panel on Dietetic Products, 2011 — EFSA Journal (2011) link

Covas et al. (EUROLIVE), 2006 — Annals of Internal Medicine (2006) link

Lopez-Huertas et al., 2017 — European Journal of Nutrition (2017) link

Cardiovascular event reduction (Mediterranean diet with EVOO)

Estruch et al. (PREDIMED), 2018 — New England Journal of Medicine (2018) link

HDL function (efflux capacity, atherogenic composition)

Hernáez et al., 2014 — Atherosclerosis (2014) link

Safety

MSKCC About Herbs — Olive — Memorial Sloan Kettering Cancer Center (2024) link

Track Hydroxytyrosol with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.